Content about Company Legal Issues

July 24, 2012
Court rules in favor of Pfizer, Northwestern University in Lyrica patent case

A district court ruled in favor of Pfizer and Northwestern University in a patent infringement case relating to Lyrica (pregabalin).

July 18, 2012
Mylan, Somaxon settle insomnia drug suit

Mylan has settled a patent litigation suit filed by Somaxon Pharmaceutical concerning an insomnia drug, Mylan said.

July 13, 2012
Federal court rules in favor of Innovation Associates in 2006 patent-infringement case

A federal judge has ruled in favor of pharmacy technology manufacturer Innovation Associates in a 6-year-old case brought by ScriptPro concerning a component of one of Innovation's dispensing robots, the companies said.

July 10, 2012
Reports: Mylan sues Warner Chilcott over antibiotic drug

Generic drug maker Mylan is suing Warner Chilcott and an Australian company, alleging that they illegally tried to protect one of their drugs from generic competition, according to published reports.

June 26, 2012
Watson seeks approval for generic antidepressant

Generic drug maker Watson Pharmaceuticals is challenging the patent protection on an antidepressant made by Pfizer, the company said.

June 25, 2012
Federal court rules against Mylan in MS drug case

A federal court has ruled against Mylan in a case filed by Teva Pharmaceutical Industries over a drug to treat multiple sclerosis.

June 19, 2012
Appeals court rules in favor of Watson in Sanctura XR patent suit

The U.S. Court of Appeals for the Federal Circuit ruled in favor of Watson Pharmaceuticals during patent litigation concerning the drug maker's abbreviated new drug application for an overactive bladder treatment.

June 18, 2012
Court rules against Merck in Nasonex patent case

Merck announced that the U.S. District Court for the District of New Jersey ruled against the company in a patent infringement suit against Canada-based drug maker Apotex.

May 29, 2012
Mylan settles with Sunovion over generic asthma, COPD drug

A unit of generic drug maker Mylan has settled with Sunovion Pharmaceuticals over a drug used to treat chronic obstructive pulmonary disease and asthma.

May 10, 2012
Watson seeks approval for generic ulcerative colitis drug

Generic drug maker Watson Pharmaceuticals is hoping to be the first to market a generic version of a drug used to treat ulcerative colitis, the company said.

May 8, 2012
NCPA seeks legislative relief to the business challenges faced by community pharmacy

Community pharmacy operators are the "canary in the coal mine" when it comes to federal or state prescription programs, said Douglas Hoey, CEO for the National Community Pharmacists Association, during a press conference held Tuesday afternoon.

April 30, 2012
Merck wins patent infringement suits against Mylan

Mylan will be barred from marketing a generic version of a Merck cardiovascular drug until the drug's patent expires, under a court ruling announced Friday.

April 3, 2012
Watson seeks approval for generic Lumigan, Latisse

Watson is challenging the patent protection on two eye drugs made by Allergan, the generic drug maker said Tuesday.

March 28, 2012
Three generic versions of psychiatric drug launched

Three companies have launched generic versions of a psychiatric drug made by AstraZeneca following a court decision turning down the Anglo-Swedish drug maker's request for an injunction against the Food and Drug Administration's approval of the generics.

March 26, 2012
Court dismisses AstraZeneca case against FDA

A federal court has dismissed a case that drug maker AstraZeneca filed against regulators regarding a drug used to treat psychotic and bipolar disorders, the company said Monday.

March 19, 2012
Watson challenges Abbott patent on Niaspan

Watson Pharmaceuticals is challenging the patent protection on a drug made by Abbott for treating cholesterol, the company said.

March 16, 2012
Amerigen joins Bystolic patent challenge

Another generic drug maker has joined efforts to challenge the patent on a drug made by Forest Labs for treating hypertension.

March 14, 2012
Forest files suit over generic versions of hypertension drug

Forest Labs has filed suit against Glenmark Generics and several other companies, alleging that they infringed on its patent for a drug to treat hypertension by seeking regulatory approval for generic versions.

February 29, 2012
Federal court upholds DEA action against Cardinal Health

A federal district court has turned down a request by Cardinal Health for an injunction against the Drug Enforcement Administration's suspension of the company's license to ship painkiller drugs from one of its distribution centers, the company said Wednesday.

February 21, 2012
Mylan resolves defamation suit against Pittsburgh Post-Gazette, two reporters

Mylan on Friday announced that the company and its subsidiary, Mylan Pharmaceuticals, have resolved the defamation and other related litigation filed by Mylan against the Pittsburgh Post-Gazette and two of its reporters.

February 14, 2012
Mylan to challenge court decision over generic asthma, COPD drug

Generic drug maker Mylan plans to challenge a court decision that requires it to pay almost $20 million to a drug company whose product it tried to market as a generic.

February 8, 2012
Watson, J&J settle lawsuit over generic contraceptive

Subsidiaries of Watson Pharmaceuticals and Johnson & Johnson have settled a lawsuit filed by the latter when Watson attempted to market a generic version of one of its contraceptive drugs.

January 27, 2012
Watson, Mallinckrodt settle over generic painkiller

Watson Pharmaceuticals and Mallinckrodt have reached a settlement concerning a painkiller for which the former had sought Food and Drug Administration approval.

January 9, 2012
Mylan seeks approval for generic diabetes drug

Generic drug maker Mylan is challenging the patent on a drug used to treat diabetes, the company said Monday.

November 21, 2011
Impax Labs looks to market generic cancer pain drug

Drug maker Impax Labs is looking to challenge the patent protection on a drug used to treat pain related to cancer, the company said Monday.

© 2013 Drug Store News. All Rights Reserved.